Gamlen Tableting to exhibit at the 2016 AAPS Annual Meeting and Exposition Thursday 27 October 2016 PDF Print Gamlen Tableting will be presenting seven posters at AAPS 2016 Gamlen Tableting will be exhibiting at the forthcoming 2016 American Association of Pharmaceutical Scientists Annual Meeting and Exposition (AAPS), 13th-17th November, at the Colorado Convention Center, Denver (Booth Number 868). Gamlen Tableting will be demonstrating Gamlen’s new manufacturability protocol which utilises data captured by the Gamlen D Series Powder Compaction Analyzer to determine whether a powder will make a good tablet. This straightforward assessment of powder properties requires just 15-25 tablets that are compressed under tightly controlled conditions using the Gamlen D Series instrument. In addition, Gamlen Tableting will be presenting seven posters at AAPS 2016 on a range of topics including: applications of the manufacturability protocol, the relationship between material and tablet properties, the effect of dwell time on tablet compressibility and the measurement of elastic recovery during and after tablet compression. Gamlen Tableting offers a range of easy-to-use bench top compaction instruments that are computer-controlled and designed for industry researchers and academics to safely explore the impact of materials and process variables on powder compaction and tablet manufacture. For further information about the Gamlen Tableting range of powder compaction analyzers and tablet presses visit: www.gamlentableting.com or telephone Gamlen Tableting Limited on: +44 (0)115 912 4271 to arrange a demonstration. ENDS Additional information • Gamlen Tableting www.gamlentableting.com was established in 2011 by Dr Michael Gamlen who has over 40 years’ experience in tablet development. Michael was Head of Tablet Development at The Wellcome Foundation for 15 years. He specialises in managing product development, formulation, and tablet and process development studies. • Gamlen instruments are used by pharmaceutical companies and prominent university teaching and research programs worldwide. For corporate and sales enquiries or to request a demonstration, please contact: Dr Michael Gamlen Managing Director Gamlen Tableting Limited Registered office: Biocity Nottingham Pennyfoot Street Nottingham NG1 1GF United Kingdom London office and demonstration laboratory: Yeoman House 63 Croydon Road London SE20 7TS United Kingdom Tel: +44 115 912 4271 Email: email@example.com Web: www.gamlentableting.com For press enquiries, please contact: Philippa Bevan Gamlen Tableting Tel: +44 1785 747 102 (direct) Email: firstname.lastname@example.org This press release was distributed by ResponseSource Press Release Wire on behalf of Gamlen Tableting in the following categories: Medical & Pharmaceutical, for more information visit http://pressreleasewire.responsesource.com/about.